JAMA Network Home
Sign In
Editorial

Are Psychedelic Agents Ready for Prime Time as Stand-Alone Treatments?

JAMA 10.1001/jama.2025.10869

September 04, 2025 at 11:00 AM EDT

Read the full article

Corresponding Author: Claudio N. Soares, MD, PhD, MBA, Centre for Psychedelic Health and Research, Providence Care Hospital, 752 King St W, Kingston, ON K7L 4X3, Canada (c.soares@queensu.ca).

Link to the article in your story

We encourage you to link out to this article in your story using the link below. It includes an access token that will give free access to the article for your readers up to one year after publication. (The link will be live after the article publishes and embargo is lifted.)

https://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2025.10869?utm_source=for_the_media&utm_medium=referral&utm_campaign=ftm_links&utm_term=090425

Copy to clipboard

Please see the article for additional information, including full author list, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.

Need more information? Contact us.

Editor's Picks